Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 30 results.
User Information
Export Records
  1. 1.   Clinical and Molecular Characterization of Microphthalmia-Associated Transcription Factor (MITF)-Related Renal Cell Carcinoma
  2. Lang, Martin; Vocke, Cathy D; Ricketts, Christopher J; Metwalli, Adam R; Ball, Mark W; Schmidt,Laura; Linehan, W Marston
  3. Urology. 2021, Mar; 149: 89-97.
  1. 2.   Genetic variation in POT1 and risk of thyroid subsequent malignant neoplasm: A report from the Childhood Cancer Survivor Study
  2. Richard, Melissa A; Lupo, Philip J; Morton, Lindsay M; Yasui, Yutaka A; Sapkota, Yadav A; Arnold, Michael A; Aubert, Geraldine; Neglia, Joseph P; Turcotte, Lucie M; Leisenring, Wendy M; Sampson, Joshua N; Chanock, Stephen J; Hudson, Melissa M; Armstrong, Gregory T; Robison, Leslie L; Bhatia, Smita; Gramatges, Maria Monica
  3. PloS one. 2020, FEB 10; 15(2): e0228887.
  1. 3.   The Metabolic Basis of Kidney Cancer
  2. Linehan, W. Marston; Schmidt,Laura; Crooks, Daniel R.; Wei, Darmood; Srinivasan, Ramaprasad; Lang, Martin; Ricketts, Christopher J.
  3. Cancer discovery. 2019, AUG; 9(8): 1006-1021.
  1. 4.   Prevalence and spectrum of germline rare variants in BRCA1/2 and PALB2 among breast cancer cases in Sarawak, Malaysia
  2. Yang, Xiaohong R; Devi, Beena C R; Sung, Hyuna; Guida, Jennifer; Mucaki, Eliseos J; Xiao, Yanzi; Best, Ana; Garland, Lisa; Xie, Yi; Hu, Nan; Rodriguez-Herrera, Maria; Wang, Chaoyu; Jones, Kristine; Luo, Wen; Hicks, Belynda; Tang, Tieng Swee; Moitra, Karobi; Rogan, Peter K; Dean, Michael
  3. Breast Cancer Research and Treatment. 2017, Oct; 165: 687-697.
  1. 5.   A comprehensive functional characterization of BRCA2 variants associated with Fanconi anemia using mouse ES cell-based assay
  2. Biswas, K.; Das, R.; Alter, B. P.; Kuznetsov, S. G.; Stauffer, S.; North, S. L.; Burkett, S.; Brody, L. C.; Meyer, S.; Byrd, R. A.; Sharan, S. K.
  3. Blood. 2011, Sep; 118(9): 2430-2442.
  1. 6.   Lack of germline PALB2 mutations in melanoma-prone families with CDKN2A mutations and pancreatic cancer
  2. Yang, X. H. R.; Jessop, L.; Myers, T.; Amundadottir, L.; Pfeiffer, R. M.; Wheeler, W.; Pike, K. M.; Yuenger, J.; Burdett, L.; Yeager, M.; Chanock, S. J.; Tucker, M. A.; Goldstein, A. M.
  3. Familial Cancer. 2011, Sep; 10(3): 545-548.
  1. 7.   Genetic Inactivation of ERK1 and ERK2 in Chondrocytes Promotes Bone Growth and Enlarges the Spinal Canal
  2. Sebastian, A.; Matsushita, T.; Kawanami, A.; Mackem, S.; Landreth, G. E.; Murakami, S.
  3. Journal of Orthopaedic Research. 2011, Mar; 29(3): 375-379.
  1. 8.   Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors
  2. Nickerson, M. L.; Jaeger, E.; Shi, Y.; Durocher, J. A.; Mahurkar, S.; Zaridze, D.; Matveev, V.; Janout, V.; Kollarova, H.; Bencko, V.; Navratilova, M.; Szeszenia-Dabrowska, N.; Mates, D.; Mukeria, A.; Holcatova, I.; Schmidt, L. S.; Toro, J. R.
  3. Clinical Cancer Research. 2008 14(15): 4726-4734.
  1. 9.   Tumor immunobiological differences in prostate cancer between African-American and European-American men
  2. Wallace, T. A.; Prueitt, R. L.; Yi, M.; Howe, T. M.; Gillespie, J. W.; Yfantis, H. G.; Stephens, R. M.; Caporaso, N. E.; Loffredo, C. A.; Ambs, S.
  3. Cancer Research. 2008 68(3): 927-936.
  1. 10.   Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer
  2. Wei, M. H.; Toure, O.; Glenn, G. M.; Pithukpakorn, M.; Neckers, L.; Stolle, C.; Choyke, P.; Grubb, R.; Middelton, L.; Turner, M. L.; Walther, M. M.; Merino, M. J.; Zbar, B.; Linehan, W. M.; Toro, J. R.
  3. Journal of Medical Genetics. 2006, JAN; 43(1): 18-27.
  1. 11.   Comprehensive analysis of CDKN2A (p16(INK4A)/p14(ARF)) and CDKN2B genes in 53 melanoma index cases considered to be at heightened risk of melanoma
  2. Laud, K.; Marian, C.; Avril, M. F.; Barrois, M.; Chompret, A.; Goldstein, A. M.; Tucker, M. A.; Clark, P. A.; Peters, G.; Chaudru, V.; Demenais, F.; Spatz, A.; Smith, M. W.; Lenoir, G. M.; Bressac-de Paillerets, B.; French Hereditary Melanoma Study, G.
  3. Journal of Medical Genetics. 2006, Jan; 43(1): 39-47.
  1. 12.   Germline BHD-mutation spectrum and phenotype analysis of a large cohort of families with Birt-Hogg-Dube syndrome
  2. Schmidt, L. S.; Nickerson, M. L.; Warren, M. B.; Glenn, G. M.; Toro, J. R.; Merino, M. J.; Turner, M. L.; Choyke, P. L.; Sharma, N.; Peterson, J.; Morrison, P.; Maher, E. R.; Walther, M. M.; Zbar, B.; Linehan, W. M.
  3. American Journal of Human Genetics. 2005, JUN; 76(6): 1023-1033.
  1. 13.   Hereditary leiomyomatosis associated with bilateral, massive, macronodular adrenocortical disease and atypical Cushing syndrome: A clinical and molecular genetic investigation
  2. Matyakhina, L.; Freedman, R. J.; Bourdeau, I.; Wei, M. H.; Stergiopoulos, S. G.; Chidakel, A.; Walther, M.; bu-Asab, M.; Tsokos, M.; Keil, M.; Toro, J.; Linehan, W. M.; Stratakis, C. A.
  3. Journal of Clinical Endocrinology & Metabolism. 2005, JUN; 90(6): 3773-3779.
  1. 14.   Early onset hereditary papillary renal carcinoma: Germline missense mutations in the tyrosine kinase domain of the met proto-oncogene
  2. Schmidt, L. S.; Nickerson, M. L.; Angeloni, D.; Glenn, G. M.; Walther, M. M.; Albert, P. S.; Warren, M. B.; Choyke, P. L.; Torres-Cabala, C. A.; Merino, M. J.; Brunet, J.; Berez, V.; Borras, J.; Sesia, G.; Middelton, L.; Phillips, J. L.; Stolle, C.; Zbar, B.; Pautler, S. E.; Linehan, W. M.
  3. Journal of Urology. 2004, OCT; 172(4): 1256-1261.
  1. 15.   A germ-line insertion in the Birt-Hogg-Dube (BHD) gene gives rise to the Nihon rat model of inherited renal cancer
  2. Okimoto, K.; Sakurai, J.; Kobayashi, T.; Mitani, H.; Hirayama, Y.; Nickerson, M. L.; Warren, M. B.; Zbar, B.; Schmidt, L. S.; Hino, O.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2004 101(7): 2023-2027.
  1. 16.   Prospective risk of cancer in CDKN2A germline mutation carriers
  2. Goldstein, A. M.; Struewing, J. P.; Fraser, M. C.; Smith, M. W.; Tucker, M. A.
  3. Journal of Medical Genetics. 2004 41(6): 421-424.
  1. 17.   Searching for the hereditary causes of renal-cell carcinoma
  2. Pavlovich, C. P.; Schmidt, L. S.
  3. Nature Reviews Cancer. 2004 4(5): 381-393.
  1. 18.   Hepatic vascular tumors, angiectasis in multiple organs, and impaired spermatogenesis in mice with conditional inactivation of the VHL gene
  2. Ma, W. B.; Tessarollo, L.; Hong, S. B.; Baba, M.; Southon, E.; Back, T. C.; Spence, S.; Lobe, C. G.; Sharma, N.; Maher, G. W.; Pack, S.; Vortmeyer, A. O.; Guo, C. F.; Zbar, B.; Schmidt, L. S.
  3. Cancer Research. 2003 63(17): 5320-5328.
  1. 19.   Studying cancer families to identify kidney cancer genes
  2. Zbar, B.; Klausner, R.; Linehan, W. M.
  3. Annual Review of Medicine-Selected Topics in the Clinical Sciences. 2003 54: 217-233.
  1. 20.   Genomic Microsatellites as evolutionary chronometers: A test in wild cats
  2. Driscoll, C. A.; Menotti-Raymond, M.; Nelson, G.; Goldstein, D.; O'Brien, S. J.
  3. Genome Research. 2002 12(3): 414-423.
  1. 21.   Genotype-phenotype relationships in US melanoma-prone families with CDKN2A and CDK4 mutations
  2. Goldstein, A. M.; Struewing, J. P.; Chidambaram, A.; Fraser, M. C.; Tucker, M. A.
  3. Journal of the National Cancer Institute. 2000 92(12): 1006-1010.
  1. 22.   VHL alterations in human clear cell renal cell carcinoma: Association with advanced tumor stage and a novel hot spot mutation
  2. Brauch, H.; Weirich, G.; Brieger, J.; Glavac, D.; Rodl, H.; Eichinger, M.; Feurer, M.; Weidt, E.; Puranakanitstha, C.; Neuhaus, C.; Pomer, S.; Brenner, W.; Schirmacher, P.; Storkel, S.; Rotter, M.; Masera, A.; Gugeler, N.; Decker, H. J.
  3. Cancer Research. 2000 60(7): 1942-1948.
  1. 23.   Signature-based analysis of MET proto-oncogene mutations using DHPLC
  2. Nickerson, M. L.; Weirich, G.; Zbar, B.; Schmidt, L. S.
  3. Human Mutation. 2000 16(1): 68-76.
  1. 24.   An important von Hippel-Lindau tumor suppressor domain mediates Sp1-binding and self-association
  2. Cohen, H. T.; Zhou, M.; Welsh, A. M.; Zarghamee, S.; Scholz, H.; Mukhopadhyay, D.; Kishida, T.; Zbar, B.; Knebelmann, B.; Sukhatme, V. P.
  3. Biochemical and Biophysical Research Communications. 1999 266(1): 43-50.
  1. 25.   Synthetic peptides define critical contacts between elongin C, elongin B, and the von Hippel-Lindau protein
  2. Ohh, M.; Takagi, Y.; Aso, T.; Stebbins, C. E.; Pavletich, N. P.; Zbar, B.; Conaway, R. C.; Conaway, J. W.; Kaelin, W. G.
  3. Journal of Clinical Investigation. 1999 104(11): 1583-1591.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel